Table 3.
Biological Processes | BDX008 | ICB | PIR (Resistant /Not Resistant) | VeriStrat |
---|---|---|---|---|
Acute inflammatory response | x | x | x | x |
Acute phase reaction | x | x | x | x |
Angiogenesis | ||||
B cell-mediated immunity | ||||
Chronic inflammatory response | x | |||
Complement activation | x | x | x | x |
Cytokine production in immune response | ||||
Epithelial-mesenchymal transition | ||||
Extracellular matrix organization | x | |||
Glycolysis activation | ||||
IFN type 1 signaling/response | x | x | ||
IFN γ signaling/response | x | x | ||
Immune tolerance/suppression | x | x | x | |
Innate immune response | x | x | ||
NK cell-meditated immunity | ||||
Response to hypoxia | ||||
T cell-mediated immunity | ||||
Type 1 immune response | ||||
Type 17 immune response | x | |||
Type 2 immune response | ||||
Wound healing | x | x |
Significant associations indicated by x.